LifeStance Health Group

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

LifeStance Health Group reports strong Q4 performance and outlines growth strategies for 2023

LifeStance Health Group's Q4 2022 performance reflects financial stability and operational strength, meeting expectations.
The company's strategic focus on long-term profitability, clinician growth, and value-based care positions it for future success.
Challenges include consolidation efforts, payer contracting complexities, and transitioning to an integrated care model.
Opportunities for growth lie in collaboration with physical care providers, value-based care models, and data-driven approaches.

LifeStance Health Group exceeds Q1 expectations, eyes sustainable growth

LifeStance Health Group's Q1 2023 performance showcased strong financial results and operational advancements, driven by clinician growth and strategic initiatives.
While facing challenges such as clinician recruitment and margin progression, the company's focus on retention and value-based care initiatives bodes well for future growth.
With opportunities in clinician expansion, operational enhancements, and market adaptation, LifeStance Health Group is poised to capitalize on emerging trends and drive sustainable success.

LifeStance Health Group excels in Q2, eyes growth opportunities

LifeStance Health Group's Q2 2023 earnings call highlighted strong financial performance, operational improvements, and a strategic focus on enhancing patient care and value-based care arrangements. The company is navigating challenges in streamlining operations and adapting to regulatory changes while capitalizing on opportunities to drive growth and operational efficiencies.

LifeStance Health Group exceeds Q3 expectations, focuses on growth

LifeStance Health Group's Q3 2023 performance reflects strong revenue growth, operational improvements, and a focus on patient and clinician satisfaction.
While facing challenges such as negative free cash flow and ongoing legal actions, the company is poised for growth through revenue guidance increases and strategic investments.
Opportunities for revenue growth, clinician expansion, and enhanced patient experiences align with the company's commitment to quality care and financial performance.
CEO Ken Burdick's emphasis on exceeding expectations, raising guidance, and navigating legal challenges underscores the company's resilience and strategic direction.

LifeStance Health Group beats 2023 metrics, focuses on growth optimization

LifeStance Health Group's strong financial performance in 2023 reflects a focus on profitability, clinician growth, and patient experience, with plans for continued optimization.
Strategic investments in technology and operational processes position the company for future success, while challenges in moderating growth and improving funnel efficiency require attention.
Opportunities lie in enhancing patient acquisition and retention, clinician productivity, and operational efficiency, leveraging the company's early growth stage for scalability.
Management's commitment to a purpose-driven culture and operational excellence, supported by a dedicated team, underpins LifeStance Health Group's path to sustained success.

LifeStance Health Group excels in Q1 2024, eyes growth opportunities

LifeStance Health Group's Q1 2024 Earnings Call showcased robust financial performance, strategic resilience, and a focus on growth. While facing leadership transitions and short-term challenges, the company is poised for positive cash flow and continued improvements in revenue and margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your LifeStance investments or would like to inquire about potentially pursuing claims to recover your loss under the fede.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) investors concerning the Company's possible violations of federal securities laws. On October 19, 2023, The Bear Cave published a report alleging that it "uncovered dozens of complaints concerning overbilling, fraudulent billing, and unfair and deceptive business practices" at LifeStance, including "allegations that L.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeStance Health Group, Inc. (NASDAQ: LFST) resulting from allegations that LifeStance may have issued materially misleading business information to the investing public. SO WHAT: If you purchased LifeStance securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency.

LFST LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages LifeStance Health Group, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – LFST

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On October 19, 2023, The Bear Cave published a report alleging that it "uncovered dozens of complaints concerning overbilling, fraudulent billing, and unfair an.

The Law Offices of Frank R. Cruz Announces Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors

SCOTTSDALE, Ariz., Oct. 18, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter earnings release before the market opens on Wednesday, November 8, 2023.

LifeStance to Host Third Quarter 2023 Earnings Conference Call on November 8, 2023

SCOTTSDALE, Ariz., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 7th Annual Bernstein Healthcare Services Disruptors Conference, which will be hosted in New York City, NY.

LifeStance to Present at the 7th Annual Bernstein Healthcare Services Disruptors Conference

SCOTTSDALE, Ariz., Aug. 28, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 21st Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY.

LifeStance to Present at the 21st Annual Morgan Stanley Healthcare Conference

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2023 Results Conference Call August 9, 2023 8:30 AM ET Company Participants Monica Prokocki - Vice President, Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Danish Qureshi - Chief Operating Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JP Morgan Jack Senft - William Blair Kevin Caliendo - UBS Jamie Perse - Goldman Sach Brian Tanquilut - Jefferies Operator Ladies and gentlemen, Thank you for standing by. My name is Desiree, and I will be your conference operator today.

LifeStance Health Group, Inc. (LFST) Q2 2023 Earnings Call Transcript

SCOTTSDALE, Ariz., Aug. 09, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2023.

LifeStance Reports Second Quarter 2023 Results

SCOTTSDALE, Ariz., July 19, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter earnings release before the market opens on Wednesday, August 9, 2023.

LifeStance to Host Second Quarter 2023 Earnings Conference Call on August 9, 2023

Bausch + Lomb Corp

Cvent Holding Corp

Leonardo DRS Inc

Penske Automotive Group

Southern Copper

Vita Coco

Corsair Gaming

EverCommerce

Evolv Technologies Holdings

Fluence Energy

Flex Lng Ltd

Hercules Capital

Instructure Holdings

IonQ

Life Time Group Holdings

Nano-X Imaging

Symbotic Inc

Target Hospitality Corp

Tootsie Roll Industries

Stocks that are difficult to sell short are likely to be overvalued, a new study finds. These fit the bill.

20 Stocks That Look Like They're in Bubble Territory Right Now

SCOTTSDALE, Ariz., May 24, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 44th Annual Goldman Sachs Healthcare Conference, which will be hosted in Dana Point, CA.

LifeStance to Present at the 44th Annual Goldman Sachs Healthcare Conference

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants Monica Prokocki - Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Danish Qureshi - Chief Operating Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Kevin Caliendo - UBS Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Operator Good day, and welcome to the LifeStance Health First Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any background noise.

LifeStance Health Group, Inc. (LFST) Q1 2023 Earnings Call Transcript

National Partnership Unites Physical and Mental Healthcare to Improve Outcomes for Menopause Patients SEATTLE and SCOTTSDALE, Ariz. , May 11, 2023 /PRNewswire/ -- Gennev , the nation's leading virtual menopause clinic provider, and LifeStance Health , one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced a partnership to deliver integrated care that helps women address both the physical and mental health symptoms associated with menopause.

Gennev and LifeStance Health Partner to Provide Integrated Care for Women in Menopause

SCOTTSDALE, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2023.

LifeStance Reports First Quarter 2023 Results

SCOTTSDALE, Ariz., April 19, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter earnings release before the market opens on Wednesday, May 10, 2023.

LifeStance to Host First Quarter 2023 Earnings Conference Call on May 10, 2023

C3.ai

BridgeBio Pharma Inc

Comerica

Enovix Corporation

First Republic

Provention Bio Inc

UMB Financial

Western Alliance Bancorporation

Zions Bancorp

March was a good month for the stock market, with the S&P 500 gaining about 3.5%.

The 5 Best- and Worst-Performing Mid-Cap Stocks in March 2023

LifeStance Health Group offers mental health services through its subsidiaries, providing solutions for individuals of all ages with a range of mental health conditions. The global mental health market is forecasted to reach $537.97 billion by 2030.

LifeStance Health Group's Position In The Booming Mental Health Market

LifeStance Health (LFST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Strength Seen in LifeStance Health (LFST): Can Its 5.5% Jump Turn into More Strength?

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2022 Earnings Conference Call March 8, 2023 8:30 AM ET Company Participants Monica Prokocki - Vice President, Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Danish Qureshi - Chief Operating Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jack Senft - William Blair Brian Tanquilut - Jefferies Jamie Perse - Goldman Sachs Kevin Caliendo - UBS Operator Ladies and gentlemen, welcome to the LifeStance Health Fourth Quarter 2022 Earnings Call. Please note today's conference is being recorded.

LifeStance Health Group, Inc. (LFST) Q4 2022 Earnings Call Transcript

LifeStance released fourth-quarter and full-year earnings on Wednesday. The company, which specializes in mental healthcare, added 200 clinicians in the quarter.

Why LifeStance Health's Shares Jumped Wednesday

SCOTTSDALE, Ariz., March 08, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2022.

LifeStance Reports Fourth Quarter and Full Year 2022 Results

LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

SCOTTSDALE, Ariz., Feb. 15, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter earnings release before the market opens on Wednesday, March 8, 2023.

LifeStance to Host Fourth Quarter and Full Year 2022 Earnings Conference Call on March 8, 2023

Addus HomeCare

Option Care Health

Pennant Group Inc

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. OPCH, LFST, ADUS and PNTG are well poised to gain from the prospects.

News for LifeStance Health Group Stock (LFST)